BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37097348)

  • 1. Impact of DWI and ADC values in Ovarian-Adnexal Reporting and Data System (O-RADS) MRI score.
    Manganaro L; Ciulla S; Celli V; Ercolani G; Ninkova R; Miceli V; Cozzi A; Rizzo SM; Thomassin-Naggara I; Catalano C
    Radiol Med; 2023 May; 128(5):565-577. PubMed ID: 37097348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Added Value of Quantitative Analysis of Diffusion-Weighted Imaging in Ovarian-Adnexal Reporting and Data System Magnetic Resonance Imaging.
    Hottat NA; Badr DA; Van Pachterbeke C; Vanden Houte K; Denolin V; Jani JC; Cannie MM
    J Magn Reson Imaging; 2022 Jul; 56(1):158-170. PubMed ID: 34797013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy and reproducibility of the O-RADS MRI risk stratification system based on enhanced non-DCE MRI in the assessment of adnexal masses.
    Wu M; Tang Q; Cai S; Zhu L; Lin C; Guan Y; Rao S; Zhou J
    Eur J Radiol; 2023 Feb; 159():110670. PubMed ID: 36584564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Adding Mean Apparent Diffusion Coefficient (ADCmean) Measurements to O-RADS MRI Scoring For Adnexal Lesions Characterization: A Combined O-RADS MRI/ADCmean Approach.
    Elshetry ASF; Hamed EM; Frere RAF; Zaid NA
    Acad Radiol; 2023 Feb; 30(2):300-311. PubMed ID: 36085271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to improve O-RADS MRI score for rating adnexal masses with cystic component?
    Assouline V; Dabi Y; Jalaguier-Coudray A; Stojanovic S; Millet I; Reinhold C; Bazot M; Thomassin-Naggara I;
    Eur Radiol; 2022 Sep; 32(9):5943-5953. PubMed ID: 35332409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of Dynamic Contrast-enhanced and Diffusion MRI to PI-RADS for Detecting Clinically Significant Prostate Cancer.
    Tavakoli AA; Hielscher T; Badura P; Görtz M; Kuder TA; Gnirs R; Schwab C; Hohenfellner M; Schlemmer HP; Bonekamp D
    Radiology; 2023 Jan; 306(1):186-199. PubMed ID: 35972360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI.
    Avendano D; Marino MA; Leithner D; Thakur S; Bernard-Davila B; Martinez DF; Helbich TH; Morris EA; Jochelson MS; Baltzer PAT; Clauser P; Kapetas P; Pinker K
    Breast Cancer Res; 2019 Dec; 21(1):136. PubMed ID: 31801635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of benign from malignant adnexal masses by functional 3 tesla MRI techniques: diffusion-weighted imaging and time-intensity curves of dynamic contrast-enhanced MRI.
    Malek M; Pourashraf M; Mousavi AS; Rahmani M; Ahmadinejad N; Alipour A; Hashemi FS; Shakiba M
    Asian Pac J Cancer Prev; 2015; 16(8):3407-12. PubMed ID: 25921153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving risk stratification of indeterminate adnexal masses on MRI: What imaging features help predict malignancy in O-RADS MRI 4 lesions?
    Wong BZY; Causa Andrieu PI; Sonoda Y; Chi DS; Aviki EM; Vargas HA; Woo S
    Eur J Radiol; 2023 Nov; 168():111122. PubMed ID: 37806193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining b2500 diffusion-weighted imaging with BI-RADS improves the specificity of breast MRI.
    Saccenti L; Mellon CM; Scholer M; Jolibois Z; Stemmer A; Weiland E; de Bazelaire C
    Diagn Interv Imaging; 2023 Sep; 104(9):410-418. PubMed ID: 37208291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative DWI implemented after DCE-MRI yields increased specificity for BI-RADS 3 and 4 breast lesions.
    Dijkstra H; Dorrius MD; Wielema M; Pijnappel RM; Oudkerk M; Sijens PE
    J Magn Reson Imaging; 2016 Dec; 44(6):1642-1649. PubMed ID: 27273694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
    J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of diffusion-weighted imaging in improving the sensitivity of LI-RADS classification of small hepatic observations suspected of malignancy.
    Basha MAA; Refaat R; Mohammad FF; Khamis MEM; El-Maghraby AM; El Sammak AA; Al-Molla RM; Mohamed HAE; Alnaggar AA; Hassan HA; Azmy TM; Alaa Eldin AM; Assy MM; AlAzzazy MZ; Altaher KM; Tantawy HF; Saber S; Amin MI; Alsowey AM; Radwan MHS; Taha HF; Fathy T; Hanafy AS; Abdelbary EH
    Abdom Radiol (NY); 2019 May; 44(5):1773-1784. PubMed ID: 30603882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance scoring system for assessment of adnexal masses: added value of diffusion-weighted imaging including apparent diffusion coefficient map.
    Hottat NA; Van Pachterbeke C; Vanden Houte K; Denolin V; Jani JC; Cannie MM
    Ultrasound Obstet Gynecol; 2021 Mar; 57(3):478-487. PubMed ID: 32438461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Features of cystadenofibroma on magnetic resonance imaging: an update using the O-RADS lexicon and considering diffusion-weighted and perfusion imaging.
    Avesani G; Elia L; Anghelone AG; Perazzolo A; Panico C; Di Paola V; Gui B; Rodolfino E; Moro F; Testa AC; Manfredi R
    Eur J Radiol; 2022 Sep; 154():110429. PubMed ID: 35797789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy and validity of the O-RADS MRI score based on a simplified MRI protocol: a single tertiary center retrospective study.
    Aslan S; Tosun SA
    Acta Radiol; 2023 Jan; 64(1):377-386. PubMed ID: 34839677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Weighted Diffusion Subtraction for Detection of Clinically Significant Prostate Cancer.
    Sato T; Isoda H; Fujimoto K; Furuta A; Fujimoto M; Ito K; Kobayashi T; Nakamoto Y
    J Magn Reson Imaging; 2021 Dec; 54(6):1979-1988. PubMed ID: 34085328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined contrast-enhanced magnetic resonance and diffusion-weighted imaging reading adapted to the "Breast Imaging Reporting and Data System" for multiparametric 3-T imaging of breast lesions.
    Pinker K; Bickel H; Helbich TH; Gruber S; Dubsky P; Pluschnig U; Rudas M; Bago-Horvath Z; Weber M; Trattnig S; Bogner W
    Eur Radiol; 2013 Jul; 23(7):1791-802. PubMed ID: 23504036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative characterization of breast tumors with diffusion-weighted imaging has comparable accuracy to quantitative analysis.
    Kul S; Metin Y; Bekircavusoglu S; Kul M
    Clin Imaging; 2021 Sep; 77():17-24. PubMed ID: 33639496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PI-RADS version 2: quantitative analysis aids reliable interpretation of diffusion-weighted imaging for prostate cancer.
    Park SY; Shin SJ; Jung DC; Cho NH; Choi YD; Rha KH; Hong SJ; Oh YT
    Eur Radiol; 2017 Jul; 27(7):2776-2783. PubMed ID: 27957637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.